Tieton Capital Management, LLC Myriad Genetics Inc Transaction History

Tieton Capital Management, LLC

$193 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$22.67 - $28.01 $2.69 Million - $3.32 Million	-118,456 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$24.13 - $32.63 $264,344 - $357,461	-10,955 Reduced 8.47%	118,456 $3.27 Million
Q3 2021 Nov 10, 2021	SELL	$29.97 - $36.66 $112,687 - $137,841	-3,760 Reduced 2.82%	129,411 $4.18 Million
Q2 2021 Aug 10, 2021	SELL	$25.39 - $32.61 $1.27 Million - $1.63 Million	-49,950 Reduced 27.28%	133,171 $4.07 Million
Q1 2021 May 10, 2021	SELL	$19.92 - $31.6 $89,938 - $142,674	-4,515 Reduced 2.41%	183,121 $5.58 Million
Q4 2020 Feb 11, 2021	SELL	$12.16 - $19.77 $77,021 - $125,223	-6,334 Reduced 3.27%	187,636 $3.71 Million
Q3 2020 Nov 12, 2020	BUY	$11.25 - $14.75 $309,701 - $406,052	27,529 Added 16.54%	193,970 $2.53 Million
Q2 2020 Aug 12, 2020	BUY	$10.69 - $16.49 $19,135 - $29,517	1,790 Added 1.09%	166,441 $1.89 Million
Q1 2020 May 11, 2020	SELL	$9.78 - $29.53 $160,284 - $483,967	-16,389 Reduced 9.05%	164,651 $2.36 Million
Q4 2019 Feb 11, 2020	BUY	$20.93 - $35.1 $192,681 - $323,130	9,206 Added 5.36%	181,040 $4.93 Million
Q3 2019 Nov 12, 2019	BUY	$22.08 - $47.08 $251,711 - $536,712	11,400 Added 7.11%	171,834 $4.92 Million
Q2 2019 Aug 09, 2019	BUY	$22.67 - $35.0 $1.41 Million - $2.18 Million	62,235 Added 63.38%	160,434 $4.46 Million
Q1 2019 May 10, 2019	BUY	$26.93 - $34.7 $2.32 Million - $2.99 Million	86,229 Added 720.38%	98,199 $3.26 Million
Q4 2018 Feb 08, 2019	SELL	$27.23 - $45.56 $2.18 Million - $3.64 Million	-79,978 Reduced 86.98%	11,970 $348,000
Q3 2018 Nov 09, 2018	SELL	$37.57 - $50.34 $1.14 Million - $1.53 Million	-30,450 Reduced 24.88%	91,948 $4.23 Million
Q2 2018 Aug 08, 2018	SELL	$27.75 - $40.17 $832 - $1,205	-30 Reduced 0.02%	122,398 $4.57 Million
Q1 2018 May 10, 2018	SELL	$28.83 - $41.01 $55,065 - $78,329	-1,910 Reduced 1.54%	122,428 $3.62 Million
Q4 2017 Feb 12, 2018	SELL	$28.45 - $37.14 $3.61 Million - $4.71 Million	-126,805 Reduced 50.49%	124,338 $4.27 Million
Q3 2017 Nov 09, 2017	BUY	$24.01 - $36.2 $6.03 Million - $9.09 Million	251,143	251,143 $9.09 Million

Others Institutions Holding MYGN

# of Institutions

250

Shares Held

90.6M

Call Options Held

100K

Put Options Held

34K

Black Rock Inc. New York, NY

15.2M
Shares

$188 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$128 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

6.72M
Shares

$83.2 Million
0.03% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

5.18M
Shares

$64.1 Million
0.07% of portfolio
State Street Corp Boston, MA

4.7M
Shares

$58.3 Million
0.01% of portfolio

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $999M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tieton Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tieton Capital Management, LLC with notifications on news.

Account